MET and neoplasm: Dysregulation of MET receptor tyrosine kinase (RTK), the only known high-affinity receptor for hepatocyte growth factor (HGF), has been implicated in tumor cell proliferation, migration, invasiveness, angiogenesis, and metastasis in a broad spectrum of human cancers [1, 2].